The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2017 | Future treatment options for multiple myeloma
Karthik Ramasamy, MBBS, MRCP, FRCPath, PhD from the Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses future treatment options for multiple myeloma at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Immunomodulatory drugs are commonly used in the treatment of multiple myeloma. The next step is combining different treatments, such as chemotherapy, steroids, and monoclonal antibodies, to achieve deeper remissions and therefore better outcomes for patients.
